REVELATION BIOSCIENCES, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $3.4M | $11.7K |
| FY2021 | — | $-99.5K | $1.3M |
| FY2022 | — | $1.1M | $5.3M |
| FY2023 | — | $6.6M | $12.0M |
| FY2024 | — | $4.7M | $6.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $3.4M | $11.7K |
| FY2021 | — | $-99.5K | $1.3M |
| FY2022 | — | $1.1M | $5.3M |
| FY2023 | — | $6.6M | $12.0M |
| FY2024 | — | $4.7M | $6.5M |